199 related articles for article (PubMed ID: 31915699)
1. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
[TBL] [Abstract][Full Text] [Related]
2. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Wang R; Li J; Xu D; Li R; Gong P
Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
[TBL] [Abstract][Full Text] [Related]
4. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
[TBL] [Abstract][Full Text] [Related]
6. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
7. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
Zuo CT; Ju Q
Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients.
Wang D; Li C; Xu Y; Xing Y; Qu L; Guo Y; Zhang Y; Sun X; Suo J
Int J Clin Exp Pathol; 2015; 8(6):6345-55. PubMed ID: 26261510
[TBL] [Abstract][Full Text] [Related]
10. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
[TBL] [Abstract][Full Text] [Related]
13. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer.
Hirajima S; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Ikoma H; Otsuji E
World J Gastroenterol; 2013 Sep; 19(36):6055-61. PubMed ID: 24106406
[TBL] [Abstract][Full Text] [Related]
14. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Nagai E; Ueyama T; Yao T; Tsuneyoshi M
Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
[TBL] [Abstract][Full Text] [Related]
17. PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China.
Qu BG; Bi WM; Qu BT; Qu T; Han XH; Wang H; Liu YX; Jia YG
Medicine (Baltimore); 2016 Apr; 95(15):e3399. PubMed ID: 27082614
[TBL] [Abstract][Full Text] [Related]
18. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
Chen Y; Qu H; Jian M; Sun G; He Q
Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
[TBL] [Abstract][Full Text] [Related]
19. Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach.
Kinjo T; Taniguchi H; Kushima R; Sekine S; Oda I; Saka M; Gotoda T; Kinjo F; Fujita J; Shimoda T
Am J Surg Pathol; 2012 Jan; 36(1):56-65. PubMed ID: 22173117
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]